We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$788M
AUM Growth
+$25.5M
Cap. Flow
-$33.5M
Cap. Flow %
-4.25%
Top 10 Hldgs %
70.45%
Holding
31
New
3
Increased
5
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
RGLS
Regulus Therapeutics
RGLS
+$23.3M
2
PGEN icon
Precigen
PGEN
+$12.2M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$1.92M
4
MZOR
Mazor Robotics Ltd.
MZOR
+$837K
5
ACOR
Acorda Therapeutics
ACOR
+$463K

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$65.5M
2
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$20.4M
3
ABEO icon
Abeona Therapeutics
ABEO
+$4.31M
4
OPK icon
Opko Health
OPK
+$3.9M
5
VANI icon
Vivani Medical
VANI
+$2.57M

Sector Composition

Rank Sector Weight
1 Healthcare 77.58%
2 Consumer Staples 0.57%
3 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$122M 15.49%
542,589
– –
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$78.7M 9.98%
2,915,633
– –
OPK icon
3
Opko Health
OPK
$1.25B
$70.3M 8.92%
4,959,335
-299,551
-6% -$3.9M
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
$65M 8.24%
3,754,343
– –
THOR
5
DELISTED
THORATEC CORPORATION
THOR
$51.6M 6.55%
1,232,600
– –
CMRX
6
DELISTED
Chimerix, Inc.
CMRX
$36.3M 4.61%
963,898
-5,502
-0.6% -$218K
ACOR
7
DELISTED
Acorda Therapeutics
ACOR
$34.8M 4.41%
8,707
+101
+1% +$463K
TTHI
8
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$33.2M 4.21%
4,861,321
– –
TSRO
9
DELISTED
TESARO, Inc.
TSRO
$31.9M 4.05%
556,379
– –
PGEN icon
10
Precigen
PGEN
$1.97B
$31.4M 3.99%
724,684
+339,110
+88% +$12.2M
ARAY icon
11
Accuray
ARAY
$29M
$31.3M 3.97%
3,366,216
-291,484
-8% -$2.32M
MZOR
12
DELISTED
Mazor Robotics Ltd.
MZOR
$24.7M 3.13%
2,198,270
+73,270
+3% +$837K
HNSN
13
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$22.6M 2.87%
2,602,798
– –
RGLS
14
DELISTED
Regulus Therapeutics
RGLS
$21.8M 2.77%
+10,726
New +$23.3M
BIOL
15
DELISTED
Biolase, Inc.
BIOL
$21.2M 2.68%
838
– –
PACB icon
16
Pacific Biosciences
PACB
$432M
$19.2M 2.43%
3,284,796
+54,278
+2% +$374K
VRML
17
DELISTED
Vermillion, Inc.
VRML
$14.4M 1.82%
8,112,182
– –
AMRN
18
Amarin Corp
AMRN
$293M
$12M 1.52%
256,572
-2,500
-1% -$76.4K
WBMD
19
DELISTED
WebMD Health Corp.
WBMD
$10.4M 1.32%
238,103
– –
AGEN
20
Agenus
AGEN
$275M
$5.98M 0.76%
59,366
+206
+0.3% +$20.6K
YTEN
21
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$4.5M 0.57%
126
-13
-9% -$416K
ABEO icon
22
Abeona Therapeutics
ABEO
$343M
$4.24M 0.54%
53,958
-53,518
-50% -$4.31M
BIIB icon
23
Biogen
BIIB
$30.4B
$3.26M 0.41%
7,723
– –
CERS icon
24
Cerus
CERS
$585M
$2.75M 0.35%
659,900
-358,605
-35% -$1.84M
VANI icon
25
Vivani Medical
VANI
$113M
$2.69M 0.34%
8,750
-9,233
-51% -$2.57M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, Oracle Investment Management held 31 positions worth $788M, up 3.3% from $763M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Oracle Investment Management withdrew a net $33.5M in Q1 2015, closing 3 positions and reducing 8 holdings. Its most notable exit was Tenet Healthcare, an estimated $65.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 81% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Oracle Investment Management opened a new position in Regulus Therapeutics worth $21.8M.

  • Oracle Investment Management's largest Q1 2015 buy was Regulus Therapeutics: 10,726 shares worth $21.8M.
  • Oracle Investment Management added most to Precigen in Q1 2015, an estimated $12.2M increase.
  • Oracle Investment Management's biggest Q1 2015 reduction was Abeona Therapeutics, cutting an estimated $4.31M.
  • Oracle Investment Management fully exited Tenet Healthcare in Q1 2015, selling an estimated $65.5M.
  • Oracle Investment Management's ten largest holdings make up 70% of its $788M portfolio in Q1 2015.
  • Oracle Investment Management opened 3 new positions and closed 3 in Q1 2015.
  • Oracle Investment Management's portfolio value rose 3.3% quarter-over-quarter to $788M.

Based on Oracle Investment Management's 13F filing for Q1 2015, filed 15 May 2015.